Summary
This post examines patents related to alcohol de-addiction in the context of Gandhian philosophy on healthy living. It reviews key inventions, including therapeutic regimens and chemical compositions for treating drug and alcohol addiction, and discusses their social significance. The analysis explores both pharmacological and behavioural intervention methods, referencing specific patent applications. The post contextualises these innovations within current legal and social frameworks, emphasising the broader impact on society and families. The discussion concludes with a call to action for adopting healthier lifestyles aligned with Gandhian values.
Patents on Alcohol and Drug De-addiction
2 October is the birth anniversary of Mohandas Karamchand Gandhi, a leader widely recognised for his advocacy of truth, non-violence, and simple living. He was a firm opponent of addictions including smoking, drinking, and substance abuse. The date is also observed globally as the International Day of Non-Violence. In that context, a review of patents relating to alcohol and drug de-addiction illustrates how inventors have approached the challenge of treating addiction through pharmaceutical and therapeutic methods.
PCT/US1982/000440 — De-addiction Therapeutic Composition
An invention disclosed in application number PCT/US1982/000440 relates to a treatment regimen for drug addicts and alcoholics. The application discloses a therapeutic composition for detoxification of drug or alcohol comprising sodium ascorbate, calcium gluconate, magnesium chloride, and thiamine hydrochloride in a saline solution compatible with blood serum. The method involves oral doses of sodium ascorbate, calcium, and magnesium administered over approximately six hours, after which the therapeutic composition is administered to complete detoxification in the absence of symptoms and cravings. Amino acids, vitamins, minerals, and proteins are subsequently administered to replenish the body. The application addresses the substantial social cost borne by families and communities affected by alcoholism.
The background section of the application notes that existing approaches to alcoholism at the time of filing included alcohol loading to induce sickness, electrode stimulus-aversion methods, and the supportive abstinence model encouraging the patient to acknowledge the severity of dependence as a precondition for recovery.
US 08/912,084 — Pyridine Nucleotide Phosphate Derivatives for Alcoholism
A further invention disclosed in application number US 08/912,084 provides a new compound and method for treating alcoholic addiction by administering pyridine nucleotide phosphate derivatives. One approach noted in the application is the administration of Nicotinamide-Adenine Dinucleotide (NAD), also known as Diphospho Pyridine Nucleotide (DPN) and coenzyme 1. NAD is also available in a phosphate form; NADP exhibits slightly different activity and resistance. The application proposes administering both NAD and NADP together to broaden the spectrum of pharmacological action.
Disclaimer
This article is for general information and does not constitute legal advice. Readers should consult a qualified attorney before acting on any matter discussed here.